Diasorin Stock Net Income
34D Stock | EUR 101.15 1.25 1.22% |
DIASORIN fundamentals help investors to digest information that contributes to DIASORIN's financial success or failures. It also enables traders to predict the movement of DIASORIN Stock. The fundamental analysis module provides a way to measure DIASORIN's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to DIASORIN stock.
DIASORIN |
DIASORIN Company Net Income Analysis
DIASORIN's Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Current DIASORIN Net Income | 310.97 M |
Most of DIASORIN's fundamental indicators, such as Net Income, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, DIASORIN is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
Competition |
Based on the recorded statements, DIASORIN reported net income of 310.97 M. This is much higher than that of the Other sector and significantly higher than that of the Other industry. The net income for all Germany stocks is notably lower than that of the firm.
DIASORIN Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses DIASORIN's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of DIASORIN could also be used in its relative valuation, which is a method of valuing DIASORIN by comparing valuation metrics of similar companies.DIASORIN is currently under evaluation in net income category among its peers.
DIASORIN Fundamentals
Current Valuation | 8.21 B | |||
Price To Book | 4.51 X | |||
Price To Sales | 5.18 X | |||
Revenue | 1.24 B | |||
EBITDA | 517.3 M | |||
Net Income | 310.97 M | |||
Total Debt | 1.23 B | |||
Cash Flow From Operations | 400.66 M | |||
Price To Earnings To Growth | 176.54 X | |||
Number Of Employees | 29 | |||
Market Capitalization | 9.85 B | |||
Total Asset | 3.23 B | |||
Z Score | 4.8 | |||
Annual Yield | 0.01 % | |||
Net Asset | 3.23 B | |||
Last Dividend Paid | 0.9 |
About DIASORIN Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze DIASORIN's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of DIASORIN using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of DIASORIN based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in DIASORIN Stock
DIASORIN financial ratios help investors to determine whether DIASORIN Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in DIASORIN with respect to the benefits of owning DIASORIN security.